首页 | 本学科首页   官方微博 | 高级检索  
     

新疆地区哈萨克族慢性阻塞性肺疾病易感性与ADAM33 基因多态性的关系
引用本文:王莎莎,关键,王珊,成芳娟,任侠,许西琳,高岩. 新疆地区哈萨克族慢性阻塞性肺疾病易感性与ADAM33 基因多态性的关系[J]. 天津医药, 2015, 43(12): 1349-1353. DOI: 10.11958/j.issn.0253-9896.2015.12.002
作者姓名:王莎莎  关键  王珊  成芳娟  任侠  许西琳  高岩
作者单位:石河子大学医学院第一附属医院呼吸内科(邮编832008)
基金项目:国家自然科学基金资助项目(81360009)
摘    要:目的探究整合素-金属蛋白酶33(ADAM33)基因F+1、S2、T1、ST+5 位点多态性与新疆地区哈萨克族慢性阻塞性肺疾病(COPD)易感性的关系。方法选择193 例对照组及197 例COPD 病例组,提取外周血标本DNA,运用SNaPshot SNP 分型技术检测ADAM33 基因各位点多态性。结果病例组与对照组F+1 位点的基因型及等位基因频率分布比较差异有统计学意义(P<0.05)。病例组中,F+1 位点CC、CT、TT 3 种基因型肺功能相关指标第1 秒用力呼气容积(FEV1)预计值(%)、FEV1/用力肺活量(FVC)比较差异无统计学意义。病例组与对照组S2、ST+5、T1 位点的基因型及等位基因频率分布比较差异无统计学意义;F+1、S2 位点进行单体型分析显示Hap1(CC)在对照组和病例组分布差异有统计学意义(P < 0.05),且OR < 1,表明此单体型可能降低发生COPD 的风险;Hap3(TC)在对照组和病例组分布差异有统计学意义(P < 0.05),且OR > 1,表明此单体型可能增加了COPD 发病的风险;Hap2(TG)、 Hap4(CG)单体型在2 组间分布差异无统计学意义;病例组及对照组T1、ST+5 位点3 种单体型比较差异无统计学意义。结论ADAM33 基因F+1 位点多态性可能与新疆哈萨克族人群COPD 的发生有关。

关 键 词:肺疾病   慢性阻塞性  ADAM 蛋白质类  多态性   单核苷酸  哈萨克族  ADAM33 基因  单体型  
收稿时间:2015-07-28
修稿时间:2015-09-01

Association between ADAM33 gene polymorphism with chronic obstructive pulmonary disease incidence in Kazakh of Xinjiang
WANG Shasha,GUAN Jian△,WANG Shan,CHENG Fangjuan,REN Xia,XU Xilin,GAO Yan. Association between ADAM33 gene polymorphism with chronic obstructive pulmonary disease incidence in Kazakh of Xinjiang[J]. Tianjin Medical Journal, 2015, 43(12): 1349-1353. DOI: 10.11958/j.issn.0253-9896.2015.12.002
Authors:WANG Shasha  GUAN Jian△  WANG Shan  CHENG Fangjuan  REN Xia  XU Xilin  GAO Yan
Affiliation:Department of Respiratory Medicine, The First Affiliated Hospital of Medical School, Shihezi University, Shihezi 832008, China
Abstract:Objective To explore correlation of Xinjiang Kazakh population who suffered from COPD with polymor⁃ phisms of F+1,S2,T1,ST+5 locus of ADAM33 gene. Methods Blood samples (n=193) from healthy controls (Control group, n=193) and COPD patients (Case group, n=197) were detected by SNP SNaP shot. Results Comparing case group with the control group, gene frequency and allele frequency of F+1 locus were of significant differences (P < 0.05). In patient group, there were no significant differences in F+1 locus genotype and in clinical indicators include lung function FEV1 predicted and FEV1/FVC (P > 0.05). The gene frequencies and allele frequency of S2、T1 and ST+5 locus were not significantly differ⁃ ent between case group and control group (P > 0.05). F+1 and S2 locus were analyzed by haplotype analysis which showed that there was significant differences in Hap1 (CC) haplotype between case group and control group (P < 0.05), and OR < 1 indicated that its haplotype may reduce the risk of COPD . There were significant differences (P < 0.05) in Hap3(TC) haplo⁃ type between case group and control group and OR > 1 revealed that its haplotype may increase the risk of COPD . The distri⁃ bution of Hap2 (TG) and Hap4 (CG) were not significantly different (P > 0.05) between the 2 groups. T1 and ST+5 locus were analyzed by haplotype analysis which showed significant differences in haplotypes between case group and control group (P < 0.05). Conclusion The occurrence of COPD may be related to the polymorphism of ADAM33 gene in F+1 locus in Xinjiang Kazakh.
Keywords:pulmonary disease   chronic obstructive  ADAM proteins  polymorphism   single nucleotide  KAZAKH NATIONALITY  ADAM33 gene  haplotype  
本文献已被 万方数据 等数据库收录!
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号